Profil
J.
Michael Grindel formerly worked at LadRx Corp., as Vice President-Drug Development, Idera Pharmaceuticals, Inc., as VP-Preclinical Development in 1997, Chimerix, Inc., as Head-Development & Program Management, R.W.
Johnson Pharmaceutical Research Institute, as Vice President-Project Planning in 1994, McNeil Pharmaceutical, as Principal in 1989, and Walter Reed Army Institute of Research, as Principal in 1976.
Ehemalige bekannte Positionen von J. Michael Grindel
| Unternehmen | Position | Ende |
|---|---|---|
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Corporate Officer/Principal | 01.01.1997 |
| R.W. Johnson Pharmaceutical Research Institute | Corporate Officer/Principal | 01.01.1994 |
| McNeil Pharmaceutical | Corporate Officer/Principal | 01.01.1989 |
| Walter Reed Army Institute of Research | Corporate Officer/Principal | 01.01.1976 |
| LADRX CORPORATION | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| LADRX CORPORATION | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
| R.W. Johnson Pharmaceutical Research Institute | |
| McNeil Pharmaceutical | |
| Walter Reed Army Institute of Research |
